Monte Rosa Therapeutics Inc Revenue per Employee (GLUE), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Monte Rosa Therapeutics Inc   (NASDAQ: GLUE)
 

Monte Rosa Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 325.8% in the third quarter 2026, year on year to cumulative value of $70 million, Monte Rosa Therapeutics Inc 's revenue per employee grew on a trailing twelve months basis to $ 468,833, this is below the company average.
Within the Healthcare sector Employees of 326 other companies have achieved higher revenue per employee. While Monte Rosa Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 2046 to 2609. Monte Rosa Therapeutics Inc has 150 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GLUE Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 325.8 % -61.33 % -95.04 % -95.41 % 38.54 %
Sales per Employee (TTM) $ 468,833 191,513 286,353 824,480 1,210,253
GLUE's Total Ranking # 2609 # 2046 # 914 # 351 #
Seq. Revenue Change 506.22 % 113.02 % 51.38 % -78.22 % -44.95 %

GLUE Company Profile >> Back to GLUE Efficiency Comparisons >> Compare GLUE Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 40
Healthcare Sector # 327
Overall Market # 2609

Revenue per Employee Statistics
High Average Low
$ 1,210,253 $ 752,367 $ 191,513
(Sep 30 2025)   (Jun 30 2026)



Financial Statements
Monte Rosa Therapeutics Inc 's Revenue MRQ $ 54 Millions Visit GLUE's Income Statement
Monte Rosa Therapeutics Inc 's Revenues TTM $ 70 Millions Visit GLUE's aggregate revenue growth
What are GLUE's Sales? Visit GLUE's Sales by Segment




Other Ratios
Monte Rosa Therapeutics Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
GLUE's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for GLUE's Competitors
Revenue per Employee for GLUE's Suppliers
Revenue per Employee for GLUE's Customers

You may also want to know
GLUE's Sales Growth Rates GLUE's Pe Price to earnings ratio GLUE's Receivables Turnover Ratio GLUE's Stock Quote
GLUE's Net Income Growth Rates GLUE's Ps Price to Sales ratio GLUE's Sales per Employee GLUE's Asset Turnover Ratio
GLUE's Net Margin GLUE's Pb Price to Book ratio GLUE's Financial Strength Ratios GLUE's Dividend Payout Ratio
Date modified: 2026-11-08T19:24:19+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Transmedics Group Inc   810,300.67 $ 727.650  Million 898 
Cerus Corporation  787,493.06 $ 226.798  Million 288 
Ars Pharmaceuticals Inc   749,300.61 $ 122.136  Million 163 
Phathom Pharmaceuticals Inc   740,919.14 $ 274.881  Million 371 
Emergent Biosolutions Inc   721,222.22 $ 649.100  Million 900 
Intuitive Surgical Inc   711,803.07 $ 12,115.600  Million 17,021 
Johnson and Johnson  705,504.26 $ 99,335.000  Million 140,800 
Mannkind Corporation  698,260.14 $ 413.370  Million 592 
Rhythm Pharmaceuticals Inc   678,135.27 $ 280.748  Million 414 
Inspire Medical Systems inc   661,810.95 $ 882.194  Million 1,333 
Caredx Inc   650,190.85 $ 497.396  Million 765 
Organon and Co   611,100.00 $ 6,111.000  Million 10,000 
Bioventus Inc   609,707.29 $ 585.319  Million 960 
Si bone inc   590,928.19 $ 222.189  Million 376 
Butterfly Network Inc   562,340.91 $ 123.715  Million 220 
Beone Medicines Ltd   550,523.25 $ 6,606.279  Million 12,000 
Novavax inc   549,598.13 $ 411.649  Million 749 
Henry Schein Inc   549,360.00 $ 13,734.000  Million 25,000 
Bausch Health Companies Inc   547,438.42 $ 11,113.000  Million 20,300 
Iradimed Corporation  538,192.16 $ 89.340  Million 166 
Glaukos Corp  528,660.88 $ 578.355  Million 1,094 
Angiodynamics Inc   512,316.46 $ 323.784  Million 632 
Resmed Inc   505,115.57 $ 5,743.164  Million 11,370 
Avantor Inc   491,525.93 $ 6,635.600  Million 13,500 
Lexicon Pharmaceuticals Inc   475,765.43 $ 38.537  Million 81 
Stryker Corp  469,642.86 $ 26,300.000  Million 56,000 
Monte Rosa Therapeutics Inc   468,833.33 $ 70.325  Million 150 
Dexcom Inc   459,900.90 $ 5,104.900  Million 11,100 
Medpace Holdings Inc   457,804.03 $ 2,838.385  Million 6,200 
Haemonetics Corporation  457,405.56 $ 1,382.737  Million 3,023 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.